Cutting-edge AI models for drug discovery are memorizing patterns rather than understanding physics, according to new research. The findings could impact development of innovative treatments for complex diseases.
A new open-source AI model called OpenFold3 aims to match Google DeepMind’s AlphaFold3 in predicting protein structures. Developed by a non-profit consortium, the tool offers unrestricted access to researchers and pharmaceutical companies. This marks a significant step toward democratizing structura
Researchers have developed GexBERT, a transformer-based AI that’s achieving breakthrough performance in cancer classification and prognosis. The model demonstrates remarkable accuracy even with limited genetic data, potentially transforming precision oncology.
